{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T17:07:14Z","timestamp":1648832834056},"reference-count":31,"publisher":"Medical Association of Nippon Medical School","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2021,4,24]]},"DOI":"10.1272\/jnms.jnms.2021_88-303","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T22:26:28Z","timestamp":1590791188000},"page":"113-120","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Gonadectomy and Angiotensin II Receptor Blockade in a Mouse Model of Isoproterenol-induced Cardiac Diastolic Dysfunction"],"prefix":"10.1272","volume":"88","author":[{"given":"Kuniya","family":"Asai","sequence":"first","affiliation":[{"name":"Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Murai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Shirakabe","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kamiya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satsuki","family":"Noma","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoichi","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Mitsukoshi Health and Welfare Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017 Oct;14 (10):591-602.","DOI":"10.1038\/nrcardio.2017.65"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gerdts E, Okin PM, de Simone G, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: The Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2008 Apr;51 (4):1109-14.","DOI":"10.1161\/HYPERTENSIONAHA.107.107474"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kostkiewicz M, Tracz W, Olszowska M, Podolec P, Drop D. Left ventricular geometry and function in patients with aortic stenosis: gender differences. Int J Cardiol. 1999 Sep 30;71 (1):57-61.","DOI":"10.1016\/S0167-5273(99)00114-X"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dent MR, Tappia PS, Dhalla NS. Gender differences in cardiac dysfunction and remodeling due to volume overload. J Card Fail. 2010 May;16 (5):439-49.","DOI":"10.1016\/j.cardfail.2009.12.017"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Douglas PS, Katz SE, Weinberg EO, Chen MH, Bishop SP, Lorell BH. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol. 1998 Oct;32 (4):1118-25.","DOI":"10.1016\/S0735-1097(98)00347-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Weinberg EO, Mirotsou M, Gannon J, Dzau VJ, Lee RT, Pratt RE. Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics. 2003 Jan 15;12 (2):113-27.","DOI":"10.1152\/physiolgenomics.00046.2002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Schwartz JB. Gender-specific implications for cardiovascular medication use in the elderly optimizing therapy for older women. Cardiol Rev. 2003 Sep-Oct;11 (5):275-98.","DOI":"10.1097\/01.crd.0000078842.86834.93"},{"key":"8","unstructured":"8. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics\u22122015 update: a report from the American Heart Association. Circulation. 2015 Jan 27;131 (4):e29-322."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Masoudi FA, Havranek EP, Smith G, et al. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol. 2003 Jan 15;41 (2):217-23.","DOI":"10.1016\/S0735-1097(02)02696-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res. 2002 Feb 15;53 (3):672-7.","DOI":"10.1016\/S0008-6363(01)00479-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Takagi G, Asai K, Vatner SF, et al. Gender differences on the effects of aging on cardiac and peripheral adrenergic stimulation in old conscious monkeys. Am J Physiol Heart Circ Physiol. 2003 Aug;285 (2):H527-34.","DOI":"10.1152\/ajpheart.01034.2002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Coulson JM, Cockcroft JR. Sex differences in the systemic response to adrenoreceptor antagonists during sympathetic activation. Eur J Clin Invest. 2011 Oct;41 (10):1129-32.","DOI":"10.1111\/j.1365-2362.2011.02521.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Seeland U, Regitz-Zagrosek V. Sex and gender differences in cardiovascular drug therapy. Handb Exp Pharmacol. 2012;211-36.","DOI":"10.1007\/978-3-642-30726-3_11"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wang J, Huertas-Vazquez A, Wang Y, Lusis AJ. Isoproterenol-induced cardiac diastolic dysfunction in mice: A systems genetics analysis. Front Cardiovasc Med. 2019 Jul 31;6:100.","DOI":"10.3389\/fcvm.2019.00100"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Oka N, Asai K, Kudej RK, et al. Downregulation of caveolin by chronic \u03b2-adrenergic receptor stimulation in mice. Am J Physiol. 1997 Dec;273 (6):C1957-62.","DOI":"10.1152\/ajpcell.1997.273.6.C1957"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Asai K, Yang GP, Geng YJ, et al. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic Gs\u03b1 mouse. J Clin Invest. 1999;104:551-8.","DOI":"10.1172\/JCI7418"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kim SJ, Yatani A, Vatner DE, et al. Differential regulation of inotropy and lusitropy in overexpressed Gs\u03b1 myocytes through cAMP and Ca2+ channel pathways. J Clin Invest. 1999 Sep 1;103 (5):1089-97.","DOI":"10.1172\/JCI4848"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Parikh KS, Sharma K, Fiuzat M, et al. Heart failure with preserved ejection fraction expert panel report: current controversies and implications for clinical trials. JACC Heart Fail. 2018 Aug;6 (8):619-32.","DOI":"10.1016\/j.jchf.2018.06.008"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Inagami T, Mizuno K, Nakamaru M, et al. The renin-angiotensin system: an overview of its intracellular function. Cardiovasc Drugs Ther. 1988 Nov;2 (4):453-8.","DOI":"10.1007\/BF00051182"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Schunkert H, Danser AH, Hense HW, et al. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation. 1997 Jan 7;95 (1):3945.","DOI":"10.1161\/01.CIR.95.1.39"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gallagher PE, Li P, Lenhart JR, Chappell MC, Brosnihan KB. Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension. 1999 Jan;33 (1 Pt 2):323-8.","DOI":"10.1161\/01.HYP.33.1.323"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Proudler AJ, Ahmed AI, Crook D, Fogelman I, Rymer JM, Stevenson JC. Hormone replacement therapy and serum angiotensin-converting enzyme activity in postmenopausal women. Lancet. 1995 Jul 8;346 (8967):89-90.","DOI":"10.1016\/S0140-6736(95)92114-1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nickenig G, B\u00e4umer AT, Groh\u00e8 C, et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation. 1998 Jun 9;97 (22):2197-201.","DOI":"10.1161\/01.CIR.97.22.2197"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Zheng W, Shi M, You SE, Ji H, Roesch DM. Estrogens contribute to a sex difference in plasma potassium concentration: a mechanism for regulation of adrenal angiotensin receptors. Gend Med. 2006 Mar;3 (1):43-53.","DOI":"10.1016\/S1550-8579(06)80193-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Armando I, Jezova M, Juorio AV, et al. Estrogen upregulates renal angiotensin II AT (2) receptors. Am J Physiol Renal Physiol. 2002 Nov;283 (5):F934-43.","DOI":"10.1152\/ajprenal.00145.2002"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Chen YF, Naftilan AJ, Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension. 1992 May;19 (5):456-63.","DOI":"10.1161\/01.HYP.19.5.456"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Miller JA, Cherney DZ, Duncan JA, et al. Gender differences in the renal response to renin-angiotensin system blockade. J Am Soc Nephrol. 2006 Sep;17 (9):2554-60.","DOI":"10.1681\/ASN.2005101095"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Saunders E, Cable G, Neutel J. Predictors of blood pressure response to angiotensin receptor blocker\/diuretic combination therapy: a secondary analysis of the irbesartan\/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) study. J Clin Hypertens (Greenwich). 2008 Jan;10 (1):27-33.","DOI":"10.1111\/j.1524-6175.2007.07195.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Os I, Franco V, Kjeldsen SE, et al. Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2008 Apr;51 (4):1103-8.","DOI":"10.1161\/HYPERTENSIONAHA.107.105296"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. O&apos;Meara E, Clayton T, McEntegart MB, et al. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007 Jun 19;115 (24):3111-20.","DOI":"10.1161\/CIRCULATIONAHA.106.673442"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Cohn JN, Tognoni G. Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001 Dec 6;345 (23):1667-75.","DOI":"10.1056\/NEJMoa010713"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/88\/2\/88_JNMS.2021_88-303\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T03:59:41Z","timestamp":1621051181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/88\/2\/88_JNMS.2021_88-303\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,24]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2021_88-303","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,24]]}}}